Centocor Ortho Biotech Services, L.L.C. clinical trials
A subsidiary of Johnson & Johnson
The registry lists 9 studies whose lead sponsor is Centocor Ortho Biotech Services, L.L.C.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 9, 2017.
Status
- Completed
- 9
Registry sponsor names on this page
- Centocor Ortho Biotech Services, L.L.C.9 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 9 of 9. All Johnson & Johnson studies →
- Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONICCompletedNCT00094458Phase 3
Sponsor listed in the registry: Centocor Ortho Biotech Services, L.L.C.
- An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.CompletedNCT00440817
Sponsor listed in the registry: Centocor Ortho Biotech Services, L.L.C.
- Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of NetherlandsCompletedNCT00731536
Sponsor listed in the registry: Centocor Ortho Biotech Services, L.L.C.
- RESTART C0168Z05 Rheumatoid Arthritis StudyCompletedNCT00714493Phase 4
Sponsor listed in the registry: Centocor Ortho Biotech Services, L.L.C.
- PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to EtanerceptCompletedNCT00527072Phase 3
Sponsor listed in the registry: Centocor Ortho Biotech Services, L.L.C.
- A Study of Human Rhinovirus Type 16 (HRV-16) Following Administration in the Nose of Healthy Adult VolunteersCompletedNCT01466738Phase 1
Sponsor listed in the registry: Centocor Ortho Biotech Services, L.L.C.
- Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to EtanerceptCompletedNCT00317538Phase 3
Sponsor listed in the registry: Centocor Ortho Biotech Services, L.L.C.
- The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) ProtocolCompletedNCT00246064Phase 4
Sponsor listed in the registry: Centocor Ortho Biotech Services, L.L.C.
- APART Advanced Profiling of Anti-Rheumatic TherapiesCompletedNCT00378261Phase 4
Sponsor listed in the registry: Centocor Ortho Biotech Services, L.L.C.